Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

NCT00003232 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

227

Enrollment

NETWORK

Sponsor class

Conditions

Pain
Prostate Cancer
Quality of Life

Interventions

DRUG: clodronate disodium
DRUG: mitoxantrone hydrochloride
DRUG: prednisone
PROCEDURE: quality-of-life assessment

Sponsor

NCIC Clinical Trials Group